If you are wondering whether DexCom at around US$64 a share looks appealing or expensive, this article breaks down what that ...

DexCom, Inc. DXCM is well positioned for growth in the coming quarters, supported by the significant potential of the continuous glucose monitoring (CGM) market. A strong fourth-quarter 2025 ...

In December, online rumors hinted at the fact that Dexcom may be planning to sunset its G6 CGM sensor model. The company has now started to notify patients of the discontinuation plan. The company ...

From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes.

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ...

Shares of DexCom Inc. DXCM slipped 3.66% to $68.10 Friday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index SPX falling 1.33% to 6,740.02 and Dow ...

U.S. stock index futures pointed to a lower open on Tuesday as renewed doubts over easing Middle East tensions tempered the ...

Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at iRhythm (NASDAQ:IRTC) and its peers. Patient monitoring companies within ...

Wall Street's main indexes opened lower on Tuesday as renewed doubts over ‌easing ⁠Middle ⁠East tensions tempered the ...

Scott Bemand is not quite sure exactly how many matches he’s watched, or miles he’s travelled, since Ireland’s agonising ...

As nanomaterials gain commercial traction, they have the potential to revolutionize medicine, aerospace, and 3D printing, and ...

Parkman Healthcare Partners initiated a 200,000-share stake in Masimo during the fourth quarter. The quarter-end position value rose by $26.01 million as a result. Masimo is not among the fund's top ...